Stability indicating densitometry-TLC assay was established and validated for determination of azelastine hydrochloride and emedastine difumarate in the presence of their acid and oxidative degradants. Forced degradation was performed using 30% H 2 O 2 and 5 M HCl. The method was based on thin-layer chromatographic separation of the two drugs from their degradants, using methanolammonia (9.5:0.5, v/v) as developing system, followed by densitometric measurements of the intact drug spots at 292 and 283 nm, respectively. The linear range was 0.5 -10.0 μg/spot, with mean recoveries of 100.09 ± 0.53% and 100.36 ± 0.40%. The proposed method was successfully applied for the routine quality control analysis of the two drugs in synthetic mixtures and commercially available preparations. The degradation products were identified by IR and MS and the pathways were illustrated. The method was validated according to ICH.
Introduction

Azelastine-HCl(AZT) is 4-(4-chlorobenzyl)-2-[(4RS)-1-methylhexahydro-1H-
azepin-4-yl] phthalazin-1(2H)-one hydrochloride [1] . It is an intranasal antihistamine indicated for use in patients with seasonal allergic rhinitis and non-allergic vasomotor rhinitis. It is also used topically in the symptomatic relief of allergic conditions including rhinitis and conjunctivitis [2, 3] . Emedastine difumarate(ETD) is 1H-benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1, 4-diazepin-1-yl), (E)-2-butenedioate(1:2) [4] . It is a second generation antihistamine used in eye drops to treat allergic conjunctivitis [5] .
forms and biological fluids are volumetric [6] , UV spectrophotometry [7] , colorimetry [7] , TLC [8] , HPLC [9] [10] [11] , and capillary electrophoresis [12] . Few methods were reported for analysis of emedastine difumarate include only HPLC with tandem MS [13, 14] or radioreceptor assay [15] detectors. The international Conference on Harmonization (ICH) guidelines recommended stress testing to elucidate the inherent stability of active substances [16] .
In the literature, no method is available so far for separation and structure elucidation of the hydrolytic and oxidative degradants of AZT and ETD. Therefore, the aim of the present work is to establish densitometry-TLC method for the selective determination of both drugs.
Experimental
Instrumentation  Shimadzu dual wavelength flying spot densitometer Model CS -9301 PC (Tokyo -Japan).
 Hamilton micro syringe (25µL).
 Aluminum plates (20 cm x 20 cm), coated with 0.2 mm layers of nano-silica gel 60 with fluorescence indicator, (Macherey -Nagel, Germany).
 UV short wavelength (254 nm) Lamp, (Desaga, Germany).
 A Bruker Vector 22 spectrometer (Bruker Instruments Ltd, Rheinstetten/ Karlsruhe, Germany) was used for recording IR spectra using KBr pellets in the range (4000 -400 cm -1 ).
 A Shimadzu GCMS-QP1000 EX quadrupole spectrometer. EI ionization was performed with an electron energy of 70 eV. The ion source temperature was .
Materials and Reagents
Azelastine-HCl was kindly supplied from European Egyptian Pharm Co., Egypt, with certified purity of 99.00%. Zalastine® Nasal Spray labeled to contain 1 mg azelastineHCl per mL (BN 7579001, European Pharm Co., Egypt) and Azelast® Eye Drops, labeled to contain 0.5 mg azelastine-HCl per mL (BN 86872, product of El-Kahira Pharm and Chem Ind Co., EPCI, Egypt) were purchased from the local market. were used.
Standard Solutions
Standard stock solutions of AZE and ETD (1 mg mL) were prepared in methanol and diluted with methanol to obtain working solutions of 5 -100 μg mL -1 for each drug.
The stock solutions were stable for one week at 4 o C.
Preparation of Degradation Products
Acid degradants
About 50 mg of azelastine-HCl or emedastine difumarate were refluxed with 50 mL 
Oxidative degradants
About 50 mg of each drug were weighed in 50 mL volumetric flask, completed to the mark with 30% H 2 O 2 , and left in the dark for 24 hours for azelastine-HCl and 6 hours for emedastine difumarate. Both solutions were evaporated to dryness under vacuum.
The residues were dissolved in 40 mL methanol and transferred separately to 50 mL volumetric flasks. The volume was completed with methanol to obtain a solution labeled to contain the oxidative degradants derived from 1 mg mL -1 of each drug.
Densitometry-TLC Method
TLC was performed on 20 x 20 cm aluminum plates precoated with silica gel F254, 10 µL of each azelastine-HCl or emedastine difumarate were applied to the plates with 25 µL Hamilton microsyringe. Ascending development of the plates, with methanol-10% ammonia(9.5:0.5, v/v) as mobile phase, was performed. After development, the plates were air-dried and scanned at 292 nm and 283 nm for AZT and ETD respectively in reflection photo mode and zigzag scan, with swing width=10.
UNDER PEER REVIEW Laboratory Prepared Mixtures
Aliquots of each standard drug solution (1 mg mL were followed. Intact drug concentrations were calculated from the corresponding regression equation.
Application to Pharmaceutical Formulations
The content of five bottles of Zalastine nasal spray or twelve bottles of Azelast eye drops were mixed and a volume equivalent to 25 mg azelastine-HCl was evaporated under vacuum. The residue was extracted with 2 x 10 mL methanol and filtered into 25 mL volumetric flask, and completed with methanol.
The contents of eighteen Emedastine 0.05% ophthalmic bottles were mixed and volume equivalent to 25 mg emedastine base was evaporated under vacuum and above details were followed. The obtained methanolic solutions labelled to contain 1 mg mL -1 of the each drug were analyzed by the proposed densitometric-TLC method as described under " Densitometry-TLC Method ". The concentration of each drug was calculated from the corresponding regression equation.
Results and Discussion
Forced degradation of both azelastine-HCl and emedastine difumarate has been studied through acid and oxidative stress conditions. Partial hydrolysis (about 50% as 
Separation and identification of degradants
The methanolic extracts of acid-hydrolysis and oxidative degradation products of each drug was tested by TLC on silica gel 60 F254 plates. Different developing systems were tried as mixture of toluene -methanol -chloroform -10% ammonia, and mixture of dichloromethane -methanol -triethylamine in different ratios no separation was achieved. Complete resolution of each drug from its degradants was detection under UV lamp at 254 nm.
For acid hydrolyzed azelastine-HCl, two spots with R f 0.66 and R f 0.84 were appeared and two spots at R f 0.73 and R f 0.86 for its oxidative degradation products.
Whereas the intact drug spot was at R f 0.59, Figure ( The degradants of each drug was subsequently separated on preparative TLC plates using the same developing solvents and extracted with methanol. The methanolic solutions were evaporated under vacuum, the residues were confirmed by IR on KBr discs and mass spectroscopy, and the results are given in Table 1 . The suggested pathway of azelastine HCl and emedastine difumarate degradation are shown in Scheme (1&2).
Method Validation[17]
Linearity range
Good correlation was found to exist between the peak areas of the separated spots and drug concentration over the range of 0.5 -10 g/spot for azelastine-HCl and emedastine difumarate as indicated by correlation coefficient ( r= 0.9993 -0.9997), Table 2 .
The limit of detection (LOD)
The LOD was calculated to be 0.031 and 0.042g/spot for azelastine-HCl and emedastine base, respectively, Table 2 .
Accuracy
The previously mentioned procedure under linearity was repeated three times for five different concentrations within the linearity range. The mean percentage recoveries were ranged between 100.09% and 100.36% for the two drugs respectively, Table 2 .
Precision
The precision of the assay (within assay and between assays) was determined for both drugs in triplicate at five concentration levels for each drug using the previous mentioned procedure under linearity in the same day 
Application of the proposed densitometric-TLC method
The proposed method was applied for the determination of the two drugs in their Statistical analysis of the results obtained by the suggested method compared with the manufacturer [18] or official method for azelastine-HCl [4] and emedastine difumarate [1] revealed no significant difference within a probability of 95%; Table   (5) . However, the proposed densitometric-TLC method is more sensitive and more selective than the manufacturer or reported methods in being stability indicating one.
The validity of the proposed method was further assured by applying the standard addition technique. The mean percentage recoveries ± RSD% were 99.74 ± 1.381 and 99.56 ± 1.121 for azelastine-HCl and 99.95 ±1.412 for emedastine base; Table (6) .
Conclusion
The suggested densitometric-TLC method proved to be pure green analytical UNDER PEER REVIEW 20 
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